Pathstone Holdings Portfolio holdings
Pathstone Holdings is the parent company of Pathstone, a privately held wealth management firm for high net worth families and institutions. Matthew Fleissig, Steve Braverman and Allan Zachariah started Pathstone in 2010 as a multi-family office owned by its partners, and Fleissig is its chief executive. Pathstone offered tax, accounting and property management as an independent firm, not part of a bank or brokerage, and it picks outside investment managers rather than selling its own products. Pathstone bought Advisor Partners, a firm that builds portfolios from an index's individual stocks, in 2022, and that business became Concentric Innovation in 2025. It also acquired Veritable LP, among the oldest multi-family offices in the US, in 2023, and merged with the wealth advisory firm Hall Capital in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$1.25B |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$1.08B |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$504M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$464M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CrowdStrike
CRWD
|
+$73.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.3M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$13.7M |
| 4 |
Microsoft
MSFT
|
+$13.2M |
| 5 |
Honeywell
HON
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.92% |
| 2 | Technology | 14.03% |
| 3 | Financials | 6.88% |
| 4 | Consumer Discretionary | 4.11% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Amplify Energy
AMPY
$146M
| $68.5K | ﹤0.01% |
17,219
-1,364
| -7% | -$7K |
2025 Q3
3 quarters
|
|
2302
Sabre
SABR
$715M
| $68.3K | ﹤0.01% |
32,703
+801
| +3% | +$1.4K |
2023 Q4
10 quarters
|
|
2303
Five Point Holdings
FPH
$315M
| $66.4K | ﹤0.01% |
12,600
-10,000
| -44% | -$50.1K |
2024 Q3
7 quarters
|
|
2304
UNIFI
UFI
$120M
| $62.2K | ﹤0.01% |
+13,102
| New | +$52.1K |
2026 Q2
0 quarters
|
|
2305
Thryv Holdings
THRY
$47.1M
| $57.1K | ﹤0.01% |
14,502
-1,864
| -11% | -$6.63K |
2026 Q1
1 quarter
|
|
2306
Santander
BSBR
$37B
| $56.1K | ﹤0.01% |
10,688
-3,609
| -25% | -$20.5K |
2025 Q3
3 quarters
|
|
2307
Tenaya Therapeutics
TNYA
$84.5M
| $55.4K | ﹤0.01% |
75,000
| – | – |
2025 Q1
5 quarters
|
|
2308
UP Fintech Holding
TIGR
$703M
| $55.3K | ﹤0.01% |
12,562
| – | – |
2023 Q4
10 quarters
|
|
2309
indie Semiconductor
INDI
$556M
| $54.5K | ﹤0.01% |
12,145
+469
| +4% | +$1.87K |
2025 Q3
3 quarters
|
|
2310
Coty
COTY
$3.82B
| $50.6K | ﹤0.01% |
23,436
+3,159
| +16% | +$6.81K |
2023 Q4
10 quarters
|
|
2311
AFC Gamma
AFCG
$78.4M
| $45.8K | ﹤0.01% |
14,758
+2,373
| +19% | +$7.46K |
2026 Q1
1 quarter
|
|
2312
B&G Foods
BGS
$216M
| $44.3K | ﹤0.01% |
11,008
+109
| +1% | +$505 |
2025 Q3
3 quarters
|
|
2313
Denison Mines
DNN
$2.01B
| $44.3K | ﹤0.01% |
14,470
-4,830
| -25% | -$16.8K |
2023 Q4
10 quarters
|
|
2314
Seer Inc
SEER
$89.1M
| $44K | ﹤0.01% |
26,510
-1,695
| -6% | -$3.08K |
2023 Q4
10 quarters
|
|
2315
Cerus
CERS
$394M
| $40.9K | ﹤0.01% |
14,000
| – | – |
2023 Q4
10 quarters
|
|
2316
BigBear.ai
BBAI
$1.12B
| $38.6K | ﹤0.01% |
+10,524
| New | +$42.1K |
2026 Q2
0 quarters
|
|
2317
Blend Labs
BLND
$257M
| $34.3K | ﹤0.01% |
20,030
-767
| -4% | -$1.22K |
2025 Q4
2 quarters
|
|
2318
San Juan Basin Royalty Trust
SJT
$197M
| $33.5K | ﹤0.01% |
10,424
| – | – |
2025 Q4
2 quarters
|
|
2319
Sol Strategies Inc
STKE
$44.9M
| $32.9K | ﹤0.01% |
28,125
| – | – |
2025 Q3
3 quarters
|
|
2320
CALL
Symbotic
SYM
$4.89B
| $32.6K | ﹤0.01% |
2,000
| – | – |
2026 Q1
1 quarter
|
|
2321
PMV Pharmaceuticals
PMVP
$65.2M
| $23.4K | ﹤0.01% |
17,487
| – | – |
2025 Q2
4 quarters
|
|
2322
Castellum
CTM
$42.8M
| $22.4K | ﹤0.01% |
31,179
| – | – |
2025 Q2
4 quarters
|
|
2323
UBS Asset Management High Yield Credit Fund
DHY
$235M
| $20.9K | ﹤0.01% |
+1,172
| New | +$20.9K |
2026 Q2
0 quarters
|
|
2324
Milestone Pharmaceuticals
MIST
$82.4M
| $20.8K | ﹤0.01% |
15,500
-1,540
| -9% | -$2.46K |
2025 Q3
3 quarters
|
|
2325
CALL
Palantir
PLTR
$407B
| $19.9K | ﹤0.01% |
400
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
Pathstone Holdings's Q2 2026 Portfolio in Review
As of Q2 2026, Pathstone Holdings held 2,429 positions worth $34.3B, up 37% from $25.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Pathstone Holdings deployed $5.75B of net new capital in Q2 2026, opening 207 new positions and adding to 1,120 existing holdings. Its largest new stake was Vanguard Total Corporate Bond ETF: 979,361 shares worth $75.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 50% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was CrowdStrike, an estimated $73.7M trimmed.
- Pathstone Holdings's largest Q2 2026 buy was Vanguard Total Corporate Bond ETF: 979,361 shares worth $75.2M.
- Pathstone Holdings added most to Vanguard Morningstar Growth ETF in Q2 2026, an estimated $1.25B increase.
- Pathstone Holdings's biggest Q2 2026 reduction was CrowdStrike, cutting an estimated $73.7M.
- Pathstone Holdings fully exited Western Asset Emerging Markets Debt Fund in Q2 2026, selling an estimated $8.89M.
- Pathstone Holdings's ten largest holdings make up 31% of its $34.3B portfolio in Q2 2026.
- Pathstone Holdings opened 207 new positions and closed 99 in Q2 2026.
- Pathstone Holdings's portfolio value rose 37% quarter-over-quarter to $34.3B.
Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.